                               SEQUENCE LISTING

<110> SAREPTA THERAPEUTICS, INC.
 
<120> EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

<130> AVN-025PC

<140>
<141>

<150> 62/356,923
<151> 2016-06-30

<150> 62/357,072
<151> 2016-06-30

<160> 10    

<170> PatentIn version 3.5

<210> 1
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
ccaatgccat cctggagttc ctgtaa                                            26


<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
caatgccatc ctggagttcc tg                                                22


<210> 3
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tgccatcctg gagttcctgt aagat                                             25


<210> 4
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
caatgccatc ctggagttcc tgtaagat                                          28


<210> 5
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
tgccatcctg gagttcctgt aagatacc                                          28


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
caatgctcct gacctctgtg c                                                 21


<210> 7
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
gctcttttcc aggttcaagt gg                                                22


<210> 8
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
gtctacaaca aagctcaggt cg                                                22


<210> 9
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 9
gcaatgttat ctgcttcctc caacc                                             25


<210> 10
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
aatgccatcc tggagttcct gtaagatacc                                        30


